Clinical trials for vaccine development in registry of Korea Food and Drug Administration.
- Author:
Seog Youn KANG
1
Author Information
- Publication Type:Brief Communication
- Keywords: Vaccine; Self-reliance; Clinical trials; Research and development
- MeSH: Immunization Programs; Korea; Marketing; Public Health; United States Food and Drug Administration; Vaccines
- From:Clinical and Experimental Vaccine Research 2013;2(1):69-70
- CountryRepublic of Korea
- Language:English
- Abstract: Based on the action plan "Ensuring a stable supply of National Immunization Program vaccines and sovereignty of biopharmaceutical products," Korea Food and Drug Administration (KFDA) has made efforts to develop vaccines in the context of self reliance and to protect public health. Along with the recognized infrastructures for clinical trials, clinical trials for vaccines have also gradually been conducted at multinational sites as well as at local sites. KFDA will support to expand six to eleven kinds of vaccines by 2017. In accordance with integrated regulatory system, KFDA has promoted clinical trials, established national lot release procedure, and strengthened good manufacturing practices inspection and post marketing surveillance. Against this backdrop, KFDA will support the vaccine development and promote excellent public health protection.
